BGM Group Ltd.
HealthcareNASDAQ:BGM · NASDAQ Global Market
+$0.03 today
Vol 0.42M · Avg 0.48M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
No earnings data available.
Income Statement
Annual data · 5 periods
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $25.1M -46.0% | $46.5M -28.3% | $64.9M +13.6% | $57.1M +14.1% | $50.0M | $921.6M | $731.2M | $843.2M |
| Cost of Revenue | $21.0M -53.1% | $44.7M -23.7% | $58.6M +13.9% | $51.5M +21.1% | $42.5M | $804.0M | $882.4M | $1.3B |
| Gross Profit | $4.1M +134.9% | $1.8M -71.9% | $6.2M +10.4% | $5.6M -25.2% | $7.5M | $7.6B | $6.2B | $4.9B |
| Gross Margin | 16.4% +12.6pp | 3.8% -5.8pp | 9.6% -0.3pp | 9.9% -5.2pp | 15.1% | 28.9% | 38.3% | 12.3% |
| Research & Development | $1.4M +139.5% | $568.5K -53.6% | $1.2M | $0 | $0 | $1.3B | $490.4M | $1.1B |
| Selling, General & Admin | $3.3M -12.6% | $3.8M +30.8% | $2.9M -10.8% | $3.3M +19.2% | $2.7M | $923.0M | -$1.5B | $732.6M |
| Operating Expenses | $4.7M +7.3% | $4.4M +5.7% | $4.1M +26.9% | $3.3M +19.2% | $2.7M | $7.0B | $8.7B | $7.3B |
| Depreciation & Amortization | $1.2M +8.2% | $1.1M -6.7% | $1.2M +2.0% | $1.2M +2.8% | $1.2M | $1.2B | $631.8M | $1.5B |
| EBITDA | $879.9K +169.0% | -$1.3M -134.1% | $3.7M -9.9% | $4.2M -42.4% | $7.2M | $6.8B | $9.3B | $11.9B |
| EBITDA Margin | 3.5% +6.2pp | -2.7% -8.5pp | 5.8% -1.5pp | 7.3% -7.1pp | 14.4% | 46.3% | 42.0% | 37.7% |
| Operating Income | -$563.8K +78.4% | -$2.6M -224.2% | $2.1M -12.0% | $2.4M -50.4% | $4.8M | $14.0B | -$15.7B | $14.3B |
| Operating Margin | -2.2% +3.4pp | -5.6% -8.9pp | 3.2% -0.9pp | 4.2% -5.4pp | 9.6% | 24.1% | 22.0% | 29.5% |
| Interest Income | $0 -100.0% | $99.2K +299.0% | $24.9K | $0 | $0 | -$1.6B | $405.0M | $561.8M |
| Interest Expense | $639.5K | $0 | $0 -100.0% | $57.7K -76.3% | $242.9K | $1.0B | $1.2B | $1.3B |
| Other Income / Expenses | -$1.6M +70.3% | -$5.3M -877.5% | -$541.4K -155.5% | $975.2K -1.9% | $994.2K | $1.4B | $1.2B | $1.1B |
| Income Before Tax | -$2.1M +73.0% | -$7.9M -606.4% | $1.6M -53.6% | $3.4M -42.1% | $5.8M | $4.9B | $3.6B | $5.3B |
| Pre-Tax Margin | -8.5% +8.5pp | -17.0% -19.4pp | 2.4% -3.5pp | 5.9% -5.7pp | 11.6% | 18.7% | 26.2% | 24.1% |
| Income Tax Expense | -$620.0K -382.9% | $219.2K +12.8% | $194.3K -23.8% | $255.1K -70.5% | $864.9K | -$1.6B | $745.2M | $1.0B |
| Net Income | -$1.4M +81.5% | -$7.8M -822.6% | $1.1M -65.9% | $3.2M -37.7% | $5.1M | $4.8B | $4.7B | -$15.5B |
| Net Margin | -5.7% +11.0pp | -16.7% -18.4pp | 1.7% -3.9pp | 5.5% -4.6pp | 10.1% | 17.5% | 22.5% | 27.5% |
| EPS (Basic) | -$0 +81.5% | -$1 -820.0% | $0 -66.7% | $0 -37.5% | $1 | $703.2M | $1.3B | $512.8M |
| EPS (Diluted) | -$0 +81.5% | -$1 -820.0% | $0 -66.7% | $0 -37.5% | $1 | $609.4M | $452.6M | $598.2M |
| Weighted Avg Shares | $7.2M +0.0% | $7.2M +0.0% | $7.2M +6.0% | $6.8M -2.6% | $7.0M | $925.8M | $1.1B | $1.3B |
| Weighted Avg Shares (Diluted) | $7.2M +0.0% | $7.2M +0.0% | $7.2M +6.0% | $6.8M -2.6% | $7.0M | $924.4M | $678.0M | -$1.5B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Twist Bioscience Corporation
NASDAQ:TWST
$4.74B
Edgewise Therapeutics, Inc.
NASDAQ:EWTX
$3.75B
Structure Therapeutics Inc.
NASDAQ:GPCR
$2.47B
Clover Health Investments, Corp.
NASDAQ:CLOV
$2.45B
Avadel Pharmaceuticals plc
AVDL
$2.12B
ANI Pharmaceuticals, Inc.
NASDAQ:ANIP
$1.86B
Mesoblast Limited
NASDAQ:MESO
$1.79B
PROCEPT BioRobotics Corporation
NASDAQ:PRCT
$1.46B
Phibro Animal Health Corporation
NASDAQ:PAHC
$1.28B
QuidelOrtho Corporation
NASDAQ:QDEL
$963.54M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does BGM generate?
BGM Group Ltd. (BGM) reported $25.10M of revenue in fiscal 2024.
Is BGM profitable?
BGM Group Ltd. (BGM) reported -$1,442,830.00 of net income, with a net margin of -5.7%.
Explore More
Continue the stock analysis
Jump to another research area for this company.